Dermagraft-TC: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
m remove <coauthors> parameter |
||
| Line 1: | Line 1: | ||
[[Image:Dermagraft.png|right|thumb|]] | [[Image:Dermagraft.png|right|thumb|]] | ||
Dermagraft-TC which is an artifical skin created from harvested foreskins from infant circumcision.<ref name='Advanced Biohealing, 2010'>{{REFweb | Dermagraft-TC which is an artifical skin created from harvested foreskins from infant circumcision.<ref name='Advanced Biohealing, 2010'>{{REFweb | ||
| quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue. | |quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue. | ||
| url=http://www.dermagraft.com/about/overview/ | |url=http://www.dermagraft.com/about/overview/ | ||
| title=Dermagraft-TC: Overview | |title=Dermagraft-TC: Overview | ||
| last= | |last= | ||
| first= | |first= | ||
| publisher=Advanced Biohealing, Inc. | |publisher=Advanced Biohealing, Inc. | ||
| website= | |website= | ||
| date= | |date= | ||
| accessdate=2011-03-06 | |accessdate=2011-03-06 | ||
}}</ref> It is made and sold by Advanced Tissue Sciences (ATS), which is a corporation based in La Jolla, CA. Dermagraft-TC is [[FDA]] approved,<ref name='MediLexicon 2011-03-06'>{{REFweb | }}</ref> It is made and sold by Advanced Tissue Sciences (ATS), which is a corporation based in La Jolla, CA. Dermagraft-TC is [[FDA]] approved,<ref name='MediLexicon 2011-03-06'>{{REFweb | ||
| quote=...fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA. | |quote=...fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA. | ||
| url=http://www.medilexicon.com/drugs/dermagraft-tc.php#GeneralInformation | |url=http://www.medilexicon.com/drugs/dermagraft-tc.php#GeneralInformation | ||
| title=Dermagraft-TC | |title=Dermagraft-TC | ||
| last= | |last= | ||
| first= | |first= | ||
| publisher=MediLexicon | |publisher=MediLexicon | ||
| website= | |website= | ||
| date= | |date= | ||
| accessdate=2011-03-06 | |accessdate=2011-03-06 | ||
}}</ref><ref name='Transplant News 2007-03-28'>{{REFnews | }}</ref><ref name='Transplant News 2007-03-28'>{{REFnews | ||
| last= | |last= | ||
| first= | |first= | ||
| coauthors= | |coauthors= | ||
| url=http://www.highbeam.com/doc/1G1-47248437.html | |url=http://www.highbeam.com/doc/1G1-47248437.html | ||
| title=Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA | |title=Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA | ||
| date=2007-03-28 | |date=2007-03-28 | ||
| publisher=Transplant News | |publisher=Transplant News | ||
| quote=...the Food and Drug Administration has approved Dermagraft-TC for marketing, making it the first human fibroblast-derived temporary skin substitute to be approved. | |quote=...the Food and Drug Administration has approved Dermagraft-TC for marketing, making it the first human fibroblast-derived temporary skin substitute to be approved. | ||
| accessdate=2011-03-06 | |accessdate=2011-03-06 | ||
}}</ref> and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of skin.<ref>{{REFjournal | }}</ref> and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of skin.<ref>{{REFjournal | ||
| last=Daecher | |last=Daecher | ||
| first=M. | |first=M. | ||
|title=Circumcision | |||
| title=Circumcision | |journal=Icon | ||
| journal=Icon | |date=1998 | ||
| date=1998 | |volume=2 | ||
| volume=2 | |issue=2 | ||
| issue=2 | |pages=70-73 | ||
| pages=70-73 | |url= | ||
| url= | |quote= | ||
| quote= | |pubmedID= | ||
| pubmedID= | |pubmedCID= | ||
| pubmedCID= | |DOI= | ||
| DOI= | |accessdate= | ||
| accessdate= | |||
}}</ref> | }}</ref> | ||
Revision as of 13:38, 15 October 2019
Dermagraft-TC which is an artifical skin created from harvested foreskins from infant circumcision.[1] It is made and sold by Advanced Tissue Sciences (ATS), which is a corporation based in La Jolla, CA. Dermagraft-TC is FDA approved,[2][3] and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of skin.[4]
References
- ↑
Dermagraft-TC: Overview
, Advanced Biohealing, Inc.. Retrieved 6 March 2011.
Quote:Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.
- ↑
Dermagraft-TC
, MediLexicon. Retrieved 6 March 2011.
Quote:...fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA.
- ↑
(28 March 2007)."Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA", Transplant News. Retrieved 6 March 2011.
Quote:...the Food and Drug Administration has approved Dermagraft-TC for marketing, making it the first human fibroblast-derived temporary skin substitute to be approved.
- ↑
Daecher, M.. Circumcision. Icon. 1998; 2(2): 70-73.
